Head Topics

Cost-Effectiveness News

Latest News On Cost-Effectiveness

Open-Source AI Challenger Emerges, Matching OpenAI's Performance on a Budget

Open-Source AI Challenger Emerges, Matching OpenAI's Performance on a Budget

2/6/2025 6:15 PM
DeepSeek's AI Model Challenges OpenAI: Cost-Effectiveness vs. Performance

DeepSeek's AI Model Challenges OpenAI: Cost-Effectiveness vs. Performance

1/30/2025 5:32 AM
Drone Flattops: The Navy's Future?

Drone Flattops: The Navy's Future?

1/25/2025 3:22 AM
Prioritizing Mental Wellness: Community-Led Prevention to Curb Costs and Crisis

Prioritizing Mental Wellness: Community-Led Prevention to Curb Costs and Crisis

1/18/2025 12:47 PM
GLP-1 Drugs For Weight Loss Aren’t Cost-Saving Yet

GLP-1 Drugs For Weight Loss Aren’t Cost-Saving Yet

1/2/2025 4:50 AM
Canadian Prison Needle Exchange Programs Show Cost Savings

Canadian Prison Needle Exchange Programs Show Cost Savings

12/19/2024 9:05 AM
Impact of Combined Lifestyle Interventions on Overweight, Obesity, and Associated Cardiometabolic Diseases

Impact of Combined Lifestyle Interventions on Overweight, Obesity, and Associated Cardiometabolic Diseases

11/30/2024 10:37 PM
Elimination Diet Best Payer Option for Initial EoE Treatment, PPI Preferred Societally

Elimination Diet Best Payer Option for Initial EoE Treatment, PPI Preferred Societally

11/27/2024 7:27 AM
Re-Assessing ‘Saint Javelin’: Crunching Anti-Tank Missile Numbers

Re-Assessing ‘Saint Javelin’: Crunching Anti-Tank Missile Numbers

11/8/2024 7:16 AM
Promising Schizophrenia Drug, Cobenfy, Will Likely Face Access Challenges

Promising Schizophrenia Drug, Cobenfy, Will Likely Face Access Challenges

11/5/2024 2:48 PM
UK’s NICE Says Alzheimer’s Disease Drug Kisunla Is Not Cost-Effective

UK’s NICE Says Alzheimer’s Disease Drug Kisunla Is Not Cost-Effective

11/2/2024 7:57 AM
Unlocking the Potential of Generative AI: Deployment Strategies for Business Success

Unlocking the Potential of Generative AI: Deployment Strategies for Business Success

10/18/2024 5:48 PM
U.K.’s Cost-Effectiveness Watchdog NICE Says No To Alzheimer’s Drug Leqembi

U.K.’s Cost-Effectiveness Watchdog NICE Says No To Alzheimer’s Drug Leqembi

9/2/2024 5:29 AM
Study Shows 58% Of Patients Discontinue Use Of Obesity Meds Before Reaching Meaningful Weight Loss

Study Shows 58% Of Patients Discontinue Use Of Obesity Meds Before Reaching Meaningful Weight Loss

6/20/2024 9:30 AM
Cost-effectiveness of Semaglutide vs ESG in People with Class II Obesity

Cost-effectiveness of Semaglutide vs ESG in People with Class II Obesity

4/12/2024 12:32 PM
California spent billions to combat homelessness without tracking if it worked, audit says

California spent billions to combat homelessness without tracking if it worked, audit says

4/12/2024 11:05 AM


Render Time: 2025-02-15 05:29:12